These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 8190022)

  • 21. Skeletal muscle insulin-receptor kinase. Effects of substrate inhibition and diabetes.
    Block NE; Komori K; Dutton SL; Robinson KA; Buse MG
    Diabetes; 1991 Dec; 40(12):1691-700. PubMed ID: 1661694
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Substrate specificity and kinetic mechanism of human placental insulin receptor/kinase.
    Walker DH; Kuppuswamy D; Visvanathan A; Pike LJ
    Biochemistry; 1987 Mar; 26(5):1428-33. PubMed ID: 3567178
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of the amino-terminal portion of human growth hormone on glucose clearance and metabolism in normal, diabetic, hypophysectomized, and diabetic-hypophysectomized rats.
    Salem MA
    Endocrinology; 1988 Sep; 123(3):1565-76. PubMed ID: 3042372
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Insulin receptor kinase activity in rat liver. Regulation by fasting and high carbohydrate feeding.
    Freidenberg GR; Klein HH; Cordera R; Olefsky JM
    J Biol Chem; 1985 Oct; 260(23):12444-53. PubMed ID: 2995376
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tests for cataglykin activity on a cyanogen bromide fragment of human growth hormone.
    Schwartz PL; McHugh NJ
    Metabolism; 1978 Jan; 27(1):1-4. PubMed ID: 619223
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Structure and in vivo activity of hypoglycaemic analogues of human growth hormone (6-13).
    Thompson P; Lim N; Ede NJ; Ng FM; Rae ID; Hearn MT
    Drug Des Discov; 1995 Aug; 13(1):55-72. PubMed ID: 8882901
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impaired insulin action but normal insulin receptor activity in diabetic rat liver: effect of vanadate.
    Blondel O; Simon J; Chevalier B; Portha B
    Am J Physiol; 1990 Mar; 258(3 Pt 1):E459-67. PubMed ID: 2180315
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of streptozocin-induced diabetes on insulin-receptor tyrosine kinase activity in obese Zucker rats.
    Slieker LJ; Roberts EF; Shaw WN; Johnson WT
    Diabetes; 1990 May; 39(5):619-25. PubMed ID: 2332119
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diabetes-associated impairment of hepatic insulin receptor tyrosine kinase activity: a study of mechanisms.
    Block NE; Komori K; Robinson KA; Dutton SL; Lam CF; Buse MG
    Endocrinology; 1991 Jan; 128(1):312-22. PubMed ID: 1846101
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Polypeptide hormone receptor phosphorylation: is there a role in receptor-mediated endocytosis of human growth hormone?
    Asakawa K; Grunberger G; McElduff A; Gorden P
    Endocrinology; 1985 Aug; 117(2):631-7. PubMed ID: 2990856
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Various proteins modulate the kinase activity of the insulin receptor.
    Yonezawa K; Roth RA
    FASEB J; 1990 Feb; 4(2):194-200. PubMed ID: 2153593
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hyperglycemic action of synthetic C-terminal fragments of human growth hormone.
    Ng FM; Bornstein J
    Am J Physiol; 1978 May; 234(5):E521-6. PubMed ID: 645904
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Isolation from subcellular preparation of a mediator of hypoglycaemic hGH peptides.
    Ng FM; Lai I; Blaskett E
    Life Sci; 1988; 42(19):1881-8. PubMed ID: 3285107
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of basic polycations and proteins on purified insulin receptor. Insulin-independent activation of the receptor tyrosine-specific protein kinase by poly(L-lysine).
    Fujita-Yamaguchi Y; Sacks DB; McDonald JM; Sahal D; Kathuria S
    Biochem J; 1989 Nov; 263(3):813-22. PubMed ID: 2557012
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sphingosine, an inhibitor of protein kinase C, suppresses the insulin-like effects of growth hormone in rat adipocytes.
    Smal J; De Meyts P
    Proc Natl Acad Sci U S A; 1989 Jun; 86(12):4705-9. PubMed ID: 2660145
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Kinase inhibition by a phosphorylated peptide corresponding to the major insulin receptor autophosphorylation domain.
    Chavanieu A; Calas B; Vaglio P; Grigorescu F
    Eur J Biochem; 1992 Sep; 208(2):367-73. PubMed ID: 1381676
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of part sequences of human growth hormone on in vivo hepatic glycogen metabolism in the rat.
    Newman JD; Armstrong JM; Bornstein J
    Biochim Biophys Acta; 1978 Dec; 544(2):234-44. PubMed ID: 214153
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Protein kinase C modulation of insulin receptor substrate-1 tyrosine phosphorylation requires serine 612.
    De Fea K; Roth RA
    Biochemistry; 1997 Oct; 36(42):12939-47. PubMed ID: 9335553
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Modulation of insulin receptor, insulin receptor substrate-1, and phosphatidylinositol 3-kinase in liver and muscle of dexamethasone-treated rats.
    Saad MJ; Folli F; Kahn JA; Kahn CR
    J Clin Invest; 1993 Oct; 92(4):2065-72. PubMed ID: 7691892
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Human growth hormone fragment (hGH44-91) produces insulin resistance and hyperinsulinemia but is less potent than 22 kDa hGH in the rat.
    Hettiarachchi M; Watkinson A; Leung KC; Sinha YN; Ho KK; Kraegen EW
    Endocrine; 1997 Feb; 6(1):47-52. PubMed ID: 9225115
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.